Wikipedia -WSS

Wikipedia

author：fashion 2025-09-30 22:27:28 - browse：8

KalVista Pharmaceuticals said Tuesday that its oral, on-demand treatment for the swelling “attacks” commonly experienced by patients with a genetic condition called hereditary angioedema achieved the goals of a Phase 3 clinical trial.

Based on the study results, the company plans to submit a marketing application to the Food and Drug Administration by the middle of the year. Regulatory filings in Europe and Japan will be completed later in the year.

In the Phase 3 study involving 136 participants, a low and high dose of Kalvista’s drug, called sebetralstat, showed a median time to the beginning of symptom relief of 1.6 hours and 1.8 hours, respectively, compared to 6.7 hours for a placebo. The result was statistically significant and achieved the study’s main efficacy goal.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Humana, CVS hope to turn members into patients at clinics

WSS

Attacks on the drug industry will lead to fewer breakthroughs

The stability of $0 premiums in Medicare Advantage

CDC: Uninsured rate hit 'record low' right as states cut Medicaid

OTC birth control: A brief history of over the counter pill design

Stem cell clinics for heart failure: buyer be wary

What the cancer research community can learn from the Covid response

knowledge

Wikipedia

knowledge

United colonoscopy coverage change 'may cost lives,' doctors say

Attacks on the drug industry will lead to fewer breakthroughs

Moonlake's readout produced a cash windfall. Risks remain

6 solutions to address cancer drug shortages and others

ChatGPT in medicine: STAT answers readers' burning questions

Nearly two

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The drug industry sees a key ally in the Senate prevail

Sports medicine is finally prioritizing gender equality

The stability of $0 premiums in Medicare Advantage

focus

Setback for rare diseases as Taysha Gene Therapies pulls back

Stem cell clinics for heart failure: buyer be wary

What Mike Pence has said that could be used in a Donald Trump trial

Setback for rare diseases as Taysha Gene Therapies pulls back

Setback for rare diseases as Taysha Gene Therapies pulls back

Setback for rare diseases as Taysha Gene Therapies pulls back

Wikipedia

leisure time

explore

knowledge